Status of antiplatelet drugs in coronary heart disease.
D001241:Aspirin / Q000494:pharmacology* / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D002994:Clofibrate / Q000494:pharmacology* / Q000627:therapeutic use; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control; D004176:Dipyridamole / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008954:Models, Biological; D010974:Platelet Aggregation / Q000187:drug effects*; D011433:Propranolol / Q000494:pharmacology* / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000494:pharmacology* / Q000627:therapeutic use
D004176:Dipyridamole; D011433:Propranolol; D002994:Clofibrate; D001241:Aspirin; D013442:Sulfinpyrazone